Rivercell

Predicting how human cells respond to treatments with AI

Overview

Rivercell is a biotechnology and AI company developing a new approach to drug discovery by predicting how human cells respond to treatments.

Combining proprietary data-generation technology, automated laboratories and advanced AI models, Rivercell is building a virtual model of the human cell capable of simulating its response to drugs and genetic changes. Its ambition is to accelerate the discovery and development of new therapies while reducing the need for costly and time-consuming laboratory experiments.

History

For founders who won’t stop
short of their vision.